Previously we observed less than 1 % event rate in patients with normal exercise thallium-201 images at a mean follow-up of 14 months. This study extends these observations over a longer follow-up period of 12-48 months (mean 27). There were 250 men and 269 women, aged 52 ±11 years (mean ± SD) of whom 64% had either typical or atypical angina pectoris. During symptom-limited exercise testing (Bruce protocol), 79 patients ( 15 %) had positive, 253 patients (49%) had negative, and the remaining patients (36%) had nondiagnostic exercise electrocardiograms. There were 255 patients (49%) who did not complete stage II of Bruce protocol. All patients had normal exercise thallium images by qualitative and quantitative analysis. During the follow-up period, there were 6 events; 2 cardiac deaths and 4 nonfatal acute myocardial infarcts occurring at 6, 12, 12, 14, 27, and 34 months after exercise testing. None of the 6 patients had positive exercise electrocardiograms and 5 patients completed stage II. All patients with events were men (2 with typical, 2 with atypical and 2 with nonanginal chest pains) giving an event rate of 0 %/year in women and 1 %/year in men. Thus, normal exercise thallium images identify a subgroup of patients at a very low risk for future cardiac events for up to 4 years irrespective of presenting symptoms, exercise tolerance and exercise electrocardiographic response. Women with normal images are particularly at a low risk.

Keywords:
Prognosis, Exercise testing, Thallium-201 imaging, Coronary artery disease
This content is only available via PDF.
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.